These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1829074)

  • 1. The post-antibiotic effect of teicoplanin: monotherapy and combination studies.
    Drabu YJ; Blakemore PH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():1-7. PubMed ID: 1829074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
    Roussel-Delvallez M; Wallet F; Barbiery P; Courcol RJ
    J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC; Simon M
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
    Røder BL; Gutschik E
    J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teicoplanin combined with various antibiotics and human blood against a multiple-drug-resistant strain of Staphylococcus aureus.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1991; 37(3):186-95. PubMed ID: 1832374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P; Joly P
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of combinations of antibiotics against Staphylococcus aureus resistant to gentamicin and methicillin.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Infection; 1985; 13(1):35-8. PubMed ID: 3845915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH; Wenzel RP
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
    Aldridge KE; Janney A; Sanders CV
    Antimicrob Agents Chemother; 1985 Nov; 28(5):634-8. PubMed ID: 2936300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antistaphylococcal agents used alone and in combinations on the survival of Staphylococcus aureus ingested by human polymorphonuclear leukocytes.
    Røder BL; Forsgren A; Gutschik E
    APMIS; 1991 Jun; 99(6):521-9. PubMed ID: 2054169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.